Turn Therapeutics effects direct listing on Nasdaq; appoints two independent directors

Turn Therapeutics Inc.

SEC declared effective S-1 for direct listing of up to 17,868,760 shares of common stock on Nasdaq Global Market.
Entered Stockholders Agreement with CEO Bradley Burnam and BEB Holdings requiring holder consent for major actions while they hold >=10% shares.
Granted registration rights to CEO/BEB Holdings including demand and piggyback registration rights.
Appointed Arthur Golden and Dr. Kent Kester as independent directors; Golden chairs Compensation Committee, Kester on Audit and Compensation.
Executed employment agreements with CEO Bradley Burnam and Zuraiz Chaudhary.

item 1.01 item 3.03 item 5.03 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Turn Therapeutics Inc.: Amended and restated bylaws became effective on September 30, 2025, as previously approved by Board and stockholders (effective 2025-09-30).

Change: bylaw amendment
Effective: 2025-09-30

Exact text from the filing

On September 30, 2025, in connection with the Direct Listing, the Company filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware, and its amended and restated bylaws (the “Bylaws”) became effective.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Turn Therapeutics Inc.: Amended and restated certificate of incorporation filed with Delaware Secretary of State on September 30, 2025, effective upon effectiveness of the Registration Statement (effective 2025-09-30).

Change: charter amendment
Effective: 2025-09-30

Exact text from the filing

On September 30, 2025, in connection with the Direct Listing, the Company filed its amended and restated certificate of incorporation (the “Certificate of Incorporation”) with the Secretary of State of the State of Delaware, and its amended and restated bylaws (the “Bylaws”) became effective.

View on SEC.gov

244 governance changes filed in the last 30 days. Browse all governance changes →

Turn Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-096003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.